A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer
Clinical trial NCT00484939 · COMPLETED
Trial details
- NCT number
- NCT00484939
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.